Pharmcogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity. Pharmacogenomics 2009;10(1):17-28 - Área de Salud Badajoz

Ir al contenido principal

Av. de Huelva, 8. 06005 Badajoz

info@areasaludbadajoz.com

info@areasaludbadajoz.com

Guía telefónica
Área de Salud

Inicio Repositorio Pharmcogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity. Pharmacogenomics 2009;10(1):17-28

2009

Pharmcogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity. Pharmacogenomics 2009;10(1):17-28

Autores/as:

Llerena A, Dorado P, Peñas-Lledó EM

Servicio:

Centro de investigación clínica del Área de Salud de Badajoz. CICAB

Tipo:

Presentación.

Materia:

Farmacocinética – Debrisoquina

{«label»:»http://www.ncbi.nlm.nih.gov/pubmed/19102711″, «link»:»http://www.ncbi.nlm.nih.gov/pubmed/19102711″}